VA Palo Alto administers 50,000 vaccine doses to Veterans, spouses and caregivers
PALO ALTO, Calif., April 22, 2021 /PRNewswire-PRWeb/ -- VA Palo Alto Health Care System (VAPAHCS) has reached 50,000 doses of COVID-19 vaccine administered to Veterans in the bay area, with even more doses administered to spouses, caregivers, and VA staff. The amount indicates nearly half of the Veterans who receive care within the healthcare system have now received their vaccine.
"There has been so much work that has gone into operating these clinics. We could not have reached this milestone without all of the support of our staff and community."" said Megan O'Connor, Interim Deputy Director for VAPAHCS and executive lead for the healthcare system's vaccine operations.
The health care system continues to provide vaccines to an even more expanded population, as the SAVE LIVES Act provides more eligibility opportunities for any Veteran who has ever joined the military, national guard or reserve. The bill also provides vaccines for their spouses and caregivers (defined as anyone who provides care such as bathing, feeding, or transportation).
Find more information about who is eligible and how to make an appointment for a vaccine on the VAPAHCS website.
Media Contact
Laura Hutcheson, VA Palo Alto Health Care System, 6508583925, [email protected]
"I'm a nurse and I thought there could be a better way to apply Epsom salt to help relieve pain and inflammation," said an inventor, from Charlotte, N.C., "so I invented the INFLAMMATION BE- GONE PAD. My design can easily and neatly be applied to the...
The Bufford Family Office is excited to announce the acquisition of The Vanguard Academy in Norton Commons. Following the recent announcement of a new school to be built on O'Bannon Station Way, the Norton Commons property will launch as the first...
Wormington & Bollinger is actively reviewing product liability cases associated with antibiotic eyedrops causing Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).
AbbVie, Inc. , a pharmaceutical company headquartered in Chicago,...
Genesis PDPA (Placentally Derived Protein Arrays) is a groundbreaking product that represents the culmination of cutting-edge research in developmental biology and harnessing the power of messaging cell factors. These PDPA cell factors are believed...
Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. breached their fiduciary duties to shareholders. The investigation concerns potential...
CSI Companies is excited to announce the appointment of Douglas Herr as Senior Vice President of Client Services and Strategy. With over 25 years of experience in healthcare, Douglas...
